Riggs Asset Managment Co. Inc. Raises Stake in iShares Biotechnology ETF (NASDAQ:IBB)

Riggs Asset Managment Co. Inc. increased its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 1,314.0% in the 3rd quarter, Holdings Channel reports. The firm owned 1,513 shares of the financial services provider’s stock after purchasing an additional 1,406 shares during the period. Riggs Asset Managment Co. Inc.’s holdings in iShares Biotechnology ETF were worth $220,000 at the end of the most recent reporting period.

A number of other large investors have also made changes to their positions in the stock. Bbjs Financial Advisors LLC acquired a new position in shares of iShares Biotechnology ETF in the second quarter valued at approximately $31,000. Eastern Bank acquired a new stake in shares of iShares Biotechnology ETF during the 3rd quarter valued at approximately $65,000. Chris Bulman Inc acquired a new stake in iShares Biotechnology ETF during the 2nd quarter valued at $64,000. BNP Paribas acquired a new position in iShares Biotechnology ETF in the first quarter valued at $69,000. Finally, Financial Perspectives Inc raised its holdings in shares of iShares Biotechnology ETF by 23.3% in the 1st quarter. Financial Perspectives Inc now owns 519 shares of the financial services provider’s stock worth $71,000 after purchasing an additional 98 shares during the period. 62.45% of the stock is currently owned by hedge funds and other institutional investors.

iShares Biotechnology ETF Stock Performance

Shares of IBB stock opened at $141.51 on Monday. iShares Biotechnology ETF has a twelve month low of $111.83 and a twelve month high of $150.57. The firm has a fifty day simple moving average of $145.56 and a 200-day simple moving average of $140.09.

iShares Biotechnology ETF Dividend Announcement

The firm also recently announced a dividend, which was paid on Monday, September 30th. Shareholders of record on Wednesday, September 25th were paid a dividend of $0.2005 per share. The ex-dividend date of this dividend was Wednesday, September 25th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.